tiprankstipranks

Aemetis price target lowered to $2.50 from $6.75 at UBS

UBS lowered the firm’s price target on Aemetis (AMTX) to $2.50 from $6.75 and keeps a Buy rating on the shares. The firm reduced estimates to reflect renewable identification numbers uncertainty, the company’s Q4 earnings miss, and low carbon fuel standard outlook. UBS views RIN pricing for 2025 as remaining unclear due to potential regulatory changes

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue